Secondary Cytoreduction in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Institution Experience

Background The purpose of this study was to observe the role of secondary cytoreductive surgery in platinum-resistant recurrent ovarian cancer (OC) patients. Methods We collected data of patients affected by recurrent OC treated between 1995 and 2013. Inclusion criteria were: invasive epithelial OC...

Full description

Saved in:
Bibliographic Details
Published in:Annals of surgical oncology 2015-12, Vol.22 (13), p.4211-4216
Main Authors: Musella, A., Marchetti, C., Palaia, I., Perniola, G., Giorgini, M., Lecce, F., Vertechy, L., Iadarola, R., De Felice, F., Monti, M., Muzii, L., Angioli, R., Panici, P. Benedetti
Format: Article
Language:English
Subjects:
Adenocarcinoma, Clear Cell - mortality
Adenocarcinoma, Clear Cell - pathology
Adenocarcinoma, Clear Cell - surgery
Adenocarcinoma, Mucinous - mortality
Adenocarcinoma, Mucinous - pathology
Adenocarcinoma, Mucinous - surgery
Adult
Aged
Cystadenocarcinoma, Serous - mortality
Cystadenocarcinoma, Serous - pathology
Cystadenocarcinoma, Serous - surgery
Cytoreduction Surgical Procedures
Drug Resistance, Neoplasm
Endometrial Neoplasms - mortality
Endometrial Neoplasms - pathology
Endometrial Neoplasms - surgery
Female
Follow-Up Studies
Gynecologic Oncology
Humans
Medicine
Medicine & Public Health
Middle Aged
Neoplasm Grading
Neoplasm Invasiveness
Neoplasm Staging
Oncology
Ovarian cancer
Ovarian Neoplasms - mortality
Ovarian Neoplasms - pathology
Ovarian Neoplasms - surgery
Platinum - pharmacology
Prognosis
Retrospective Studies
Surgery
Surgical Oncology
Survival Rate
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The purpose of this study was to observe the role of secondary cytoreductive surgery in platinum-resistant recurrent ovarian cancer (OC) patients. Methods We collected data of patients affected by recurrent OC treated between 1995 and 2013. Inclusion criteria were: invasive epithelial OC histologically documented, cytoreductive surgery and platinum-based chemotherapy at first-line treat ment with evidence of complete response to treatment, disease-free interval
ISSN:1068-9265
1534-4681
DOI:10.1245/s10434-015-4523-2